What’s interesting regarding the discussion of Mulholland selling shares is that the many of the same investors praising Mulholland for selling (“yes, take profits, you deserve it,” “it was preplanned,” “he’s giving money back to the company,”) are the same investors who lambasted Pfizer and Moderna executives for selling shares around their data releases and attempted to relate, in a negative manner, the selling of those shares to a rushed vaccine. I’m on board with Mulholland as he should take profits when he can, but confirmation bias is strong with biotech investors.